-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Nurix Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2020 to Q1 2024.
- Nurix Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending February 29, 2024 was $1.62M, a 9.66% increase year-over-year.
- Nurix Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $486M, a 14997% increase from 2023.
- Nurix Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.22M, a 97.3% decline from 2022.
- Nurix Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $117M, a 23.8% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)